Streetbeat News

Price Targets

AZO

Evercore ISI analyst Greg Melich upgrades AutoZone (NYSE:AZO) from In-Line to Outperform, raising the price target from $2,640 to $2,700. The analyst cites favorable industry drivers, strong web traffic gains, and an attractive entry point after a 6% price decline since reporting quarterly results.

Portfolio Pulse from Nabaparna Bhattacharya

June 12, 2023 | 5:04 pm

SAPIF

TD Securities analyst Michael Aelst maintains a Buy rating on Saputo (OTC:SAPIF) and lowers the price target from C$46 to C$42.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 5:03 pm

PL

Morgan Stanley maintains its Equal-Weight rating for Planet Labs (NYSE:PL) and lowers its price target from $6.00 to $5.50. Shares of Planet Labs are trading up 0.44% over the last 24 hours, at $3.42 per share.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 5:02 pm

MU

Over the past 3 months, 15 analysts have published their opinion on Micron Technology (NASDAQ:MU) stock, with an average 12-month price target of $76.2. The average price target has increased by 20.8% over the past month.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 5:01 pm

AMZN

B of A Securities maintains its Buy rating for Amazon.com (NASDAQ:AMZN) and raises its price target from $139 to $154, representing a 22.71% increase from the current share price. Amazon shares are trading up 1.67% over the last 24 hours.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 5:01 pm

SOFI

Truist Securities maintains its Buy rating for SoFi Techs (NASDAQ:SOFI) and raises its price target from $8.00 to $11.00. Shares of SoFi Techs are trading up 10.02% over the last 24 hours, at $9.00 per share.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 5:00 pm

NIO

Morgan Stanley analyst Tim Hsiao reiterated an Overweight rating on NIO (NYSE:NIO) and maintained a $12 price target.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 4:55 pm

COGT

Piper Sandler analyst Christopher Raymond maintains an Overweight rating on Cogent Biosciences (NASDAQ:COGT) and keeps the $22 price target.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 4:45 pm

KDNY

Cantor Fitzgerald analyst Charles Robertson II downgraded Chinook Therapeutics (NASDAQ:KDNY) from Overweight to Neutral and announced a $40 price target.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 4:43 pm

APTO

Aptose Biosciences' stock is trading higher after several firms increased their price targets for the company.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 4:39 pm